NBY News and Press, NovaBay Pharmaceuticals Inc. From 08/09/23

2023-08-09 17:35:09 ET NovaBay ( NYSE: NBY ) is scheduled to announce Q2 earnings results on Thursday, August 10th, after market close. The consensus EPS Estimate is -$0.56 and the consensus Revenue Estimate is $3.67M (+20.7% Y/Y). Over the last 3 months, EPS estimates...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2023 after market close on Thursday, August 10, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, July 20, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the closing of a pr...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that sales of Avenova ® -branded products reached a new record during the Amazon Prime Day event held July 11-1...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces special pricing on Avenova ® -branded products to Amazon prime members during Prime Day 2023, being held July 1...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that it will be sponsoring dry eye educational programs and offering special promotions on its Avenova ® -branded e...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that it will showcase its Avenova ® -branded eyecare products at the 126 th Annual American Optometric Associat...

Chief Product Officer Dr. Audrey Kunin to showcase KP Duty combo with supercharged exfoliators and moisturizers to help rapidly lift away dry, rough bumps and reveal healthier looking skin NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and comme...

MONTREAL, June 09, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the results of its annual general meeting (“AGM”) of shareholders held on June 8, 2023. Shareholders holdin...

--News Direct-- NovaBay Pharmaceuticals CEO Justin Hall joined Steve Darling from Proactive to talk more about the company that has developed scientifically proven eye care, skin care and wound care products. The company's top product is Avenova, which has proven in laboratory testing to ...